Rolvedon
NDC 82497-132, eflapegrastim-xnst, injection, solution, from Assertio Specialty Pharmaceuticals, LLC.
- Product NDC
- 82497-132
- Status
- Listed
- Labeler
- Assertio Specialty Pharmaceuticals, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761148
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82497-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EFLAPEGRASTIM13.2 mg/.6mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82497-132-01 | 82497013201 | .6 mL in 1 SYRINGE, GLASS (82497-132-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2dc62c46-bb10-4a62-a459-d3eeeb6dd82fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=82497-132
Use it
Look up 82497-132 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82497-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82497-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.